Congratulations to Karmanos' Office of Community Outreach and Engagement for being named a 2025 Hometown Health Hero by the Michigan Public Health Week Partnership! #YourBestChance
https://t.co/wJeAiuJTvf
Proud to be part of #ICE2025 group riding across Iceland this summer, raising $ for multiple #myeloma research! Link takes you right to the place where you can make a difference: https://t.co/siNQYOjJ3G. Every dollar counts!
It’s time! I’m raising $ to support #myeloma research as part of the #ICE2025 biking team headed to Iceland later this summer. Biking? Me? No mountains? YEP! and 100% of the $ raised goes to support innovative cancer research. Support by clicking here: https://t.co/siNQYOkgTe
Ramadan Kareem (Ramzan Mubarak) to all friends and colleagues observing the holy month. May hope, humanity and peace prevail in these troubled times. #MedTwitter
WORTH WATCHING: This is an excellent series of 11 short videos with three amyloidosis experts: Heather Landau, MD; Vaishali Sanchorawala, MD; and Jeffrey Zonder, MD where they are discussing Light Chain (AL) amyloidosis. Topics they discuss include: signs and symptoms, diagnosis, and treatments (today and looking ahead).
#MedEd
#amyloidosis
https://t.co/rnEYdGA4Sv
Hanna and her lovely family (our two honorary fellows as she calls them) her husband Tom and her daughter Larissa, help organize all our events: our graduation parties, baby showers for our fellows, picnics, creating an anonymous suggestion box. We would be so lost without Hanna!
Introducing the heart of our program, our program coordinator, Hanna Carlson:
She’s our momma bear!!! She makes sure we’re well-fed, well-caffeinated, well-rested and keeps us all on track. She is extremely organized and makes our recruitment process seamless. 🧵
Over and out from #ISA_2022! Great to see old friends and meet new ones! Lots of data and ideas to unpack. Thanks to our hosts in Heidelberg for a terrific meeting! @silvapregja#amyloidosis
@BU_Amyloidosis#asct for AL #amyloidosis. Great presentation on value of achieving MRD(-) status. Take home: it improves hematologic control & freq of renal response (but not heart or all-organ response). MOD-PFS still really heme PFS like in ANDROMEDA #ISA_2022
…and #ISA_2022 day #2 is underway with a challenging session on the challenging topic of MGRS. Further proof that every #myeloma and #amyloidosis MDT should include a #nephrology doc.